MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the new health care reform law - PL 111-148, specifically with regard to those provisions impacting Medicare/Medicaid prescription drug coverage, the essential benefit pkg., and other matters.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARTI SHAH | — |
Medicare/Medicaid MMM
HR 4302 Protecting Access to Medicare Act of 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARTI SHAH | — |
Budget/Appropriations BUD
H. Con. Res. 96-- Establishing the budget for the U.S. Government for FY 2015 and setting forth appropriate budgetary levels for FY 2016 through 2024 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARTI SHAH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.